Kanova Biopharma
PrivateLast Round
VC Round
Apr 29, 2026
Total Funding Raised
$40.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Kanova Biopharma is a biopharmaceutical company that develops first-in-class therapeutic antibodies and innovative combination therapies for the treatment of cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kanova Biopharma Comparables
Compare Kanova Biopharma with similar companies based on industry and business-model similarity.
No public comparables are available for Kanova Biopharma. Request access to learn about comparables coverage.
Request accessKanova Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 29, 2026 | ||||
| Series B Extension | Jul 1, 2023 | ||||
| Series B | Jul 13, 2021 | ||||
| Series A | Nov 1, 2018 |
Kanova Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Beijing E-Town International Investment & Development Co., Ltd. | VC Round |
| 3H Health Investment | Series B |
| Caleb Capital | VC Round |
| Lotus Lake Capital Management | Series B |
| Shenzhen GTJA Investment Group | Series B Extension |
| CD Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 29, 2026
Led by Beijing E-Town International Investment & Development Co., Ltd.
- Jul 1, 2023
$14M round led by Shenzhen GTJA Investment Group.
Kanova Biopharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Kanova Biopharma's valuation, stock price, and market status.
Is Kanova Biopharma a public or private company?
Kanova Biopharma is a private company.
What is the current stock price of Kanova Biopharma?
Kanova Biopharma is a private company, so its shares have no public market price. Caplight tracks Kanova Biopharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kanova Biopharma worth (valuation)?
Valuation information for Kanova Biopharma is not publicly available.
Can I buy Kanova Biopharma stock?
Kanova Biopharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kanova Biopharma's last funding round?
Kanova Biopharma's most recent funding round was VC Round on April 29, 2026.
Who are the main investors in Kanova Biopharma?
Key investors in Kanova Biopharma include Beijing E-Town International Investment & Development Co., Ltd., Shenzhen GTJA Investment Group, CD Capital.
Will Kanova Biopharma IPO soon?
No public IPO plans have been announced for Kanova Biopharma.
How can I track Kanova Biopharma secondary market activity?
Caplight tracks bids, offers, and trades in Kanova Biopharma's shares on secondary markets.